Compare Baxter International Inc (BAX) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $107.03. The key difference: Baxter International Inc pays a 0.92% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none, and Baxter International Inc is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| BAX | LQD | |
|---|---|---|
Market Cap | $11.26B | — |
Sector | Health | — |
52-Week High | $29.22 | $112.91 |
52-Week Low | $15.80 | $106.96 |
Enterprise Value | $18.93B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
LQD, the iShares iBoxx $ Investment Grade Corporate Bond ETF, trades at $106.96, down 0.47% on the day. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators suggest potential oversold conditions. Recent dividend payouts of $0.38-$0.42 per share highlight its income focus. Fixed income ETFs are gaining investor attention amid economic resilience and rate uncertainty, with bond inflows surging 60% year-over-year as of June 2026 (CNBC, 2026-06-25).
Outlook: LQD offers exposure to investment-grade corporate bonds with steady dividends, but faces headwinds from potential Fed rate hikes and inflation concerns. Risks include interest rate sensitivity and narrowing market breadth. Analyst comparisons favor LQD for lower drawdowns versus peers, but investors should weigh yield against Treasury alternatives. The ETF's performance hinges on macroeconomic policy shifts and corporate debt market stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
